Research and development
The European Medicines Agency (EMA) provides guidance and support to companies researching and developing veterinary medicines. This includes scientific and regulatory information on how to design and run clinical trials, compliance standards, how to establish maximum residue limits for medicines and biocides, support to innovation, and incentives for companies developing medicines for minor use / minor species (MUMS) / limited markets.
United Kingdom's (UK) withdrawal from the European Union (EU)
EMA has published important information to help users of the centralised procedure prepare for the expected consequences of 'Brexit', including their obligations related to establishment within the European Economic Area (EEA). For more information, see UK's withdrawal from the EU.